JPRN-UMIN000005062已完成未知
Switching test from latanoprost to travoprost/timolol ophthalmic solution - Switching test to travoprost/timolol ophthalmic solution
Association for Research in Supporting System of Chronic Diseases0 个研究点目标入组 60 人开始时间: 2011年2月13日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •active ocular diseases, severe heart and pulmonary diseases, history of allergy against employed ophthalmic solutions, less than six months after any incisional ocular surgery and ocluar trauma, and any other conditions that doctor recognizes inadequate for enrollment
研究者
相似试验
已完成
不适用
Switching from latanoprost or travoprost ophthalmolic solution to tafruprost and timolol fixed ophthalmic solutioPrimary open angle glaucoma and ocular hypertensionJPRN-UMIN000015823niversity of Yamanashi40
招募中
不适用
Assessing the efficacy of changing to Travoprost/Timolol fixed combination, as replacement therapy in patients on prostaglandin monotherapyGlaucomaJPRN-UMIN000007028I.CHANGE study group180
已完成
不适用
Comparison of travoprost and latanoprost plus timolol fixed combinations in open-angle glaucoma and ocular hypertension patients previously treated with dorzolamide plus timolol fixed combination.primary open angle glaucoma, normal tension glaucoma and ocular hypertension patientsJPRN-UMIN000005974Department of Ophthalmology, National Defense Medical College70
已完成
3 期
Travoprost 0.004%/Timolol 0.5% Versus Latanoprost 0.005%/Timolol in Chinese Patients With Open-Angle Glaucoma or Ocular HypertensionOpen-angle GlaucomaOcular HypertensionNCT00872651Alcon Research242
已完成
不适用
Efficacy and safety of a switch to latanoprost 0.005% + timolol maleate 0.5% fixed combination eyedrops from tafluprost 0.0015% monotherapy.glaucomaJPRN-UMIN000017687Department of Ophthalmology, Keio University School of Medicine50